The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer
Seon‐Kyu Kim(Center for Genomic Science), Hyun‐Soo Cho(Korea Research Institute of Bioscience and Biotechnology)
Cited by 37
Related Papers
Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
|Cancer Science|2011|191
Human gut-microbiome-derived propionate coordinates proteasomal degradation via HECTD2 upregulation to target EHMT2 in colorectal cancer
|The ISME Journal|2022|130
Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B
|Nature Communications|2012|113